CryoLife Inc logo

CRY - CryoLife Inc Share Price

$20.01 -0.2  -0.9%

Last Trade - 6:32pm

Mid Cap
Market Cap £583.2m
Enterprise Value £726.8m
Revenue £210.5m
Position in Universe 2548th / 6366
Unlock CRY Revenue
Relative Strength (%)
1m +0.079%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -36.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
144.6 145.9 180.4 189.7 262.8 276.2 250.6 289.5 +13.8%
-61.2 -45.7 +31.9 -45.3 -51.3 +204.3
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Cryolife Inc revenues decreased 2% to $66.4M. Net loss applicable to common stockholders increased from $295K to $6.6M. Revenues reflect Medical Devices segment decrease of 4% to $46.3M. Higher net loss reflects Other (income) expense, net increase from $77K to $3.7M (expense), General, administrative, and marketing - increase of 10% to $36M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


CRY Revenue Unlock CRY Revenue

Net Income

CRY Net Income Unlock CRY Revenue

Normalised EPS

CRY Normalised EPS Unlock CRY Revenue

PE Ratio Range

CRY PE Ratio Range Unlock CRY Revenue

Dividend Yield Range

CRY Dividend Yield Range Unlock CRY Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CRY EPS Forecasts Unlock CRY Revenue
Profile Summary

CryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife's SynerGraft technology.

Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated January 19, 1984
Public Since February 12, 1993
No. of Shareholders: 218
No. of Employees: 1,200
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P 600 Small Cap , S&P Composite 1500 ,
Exchange New York Stock Exchange
Shares in Issue 37,740,425
Free Float (0.0%)
Eligible for
CRY Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CRY
Upcoming Events for CRY
Wednesday 28th October, 2020 Estimate
Q3 2020 CryoLife Inc Earnings Release
Frequently Asked Questions for CryoLife Inc
What is the CryoLife Inc share price?

As of 6:32pm, shares in CryoLife Inc are trading at $20.01, giving the company a market capitalisation of £583.2m. This share price information is delayed by 15 minutes.

How has the CryoLife Inc share price performed this year?

Shares in CryoLife Inc are currently trading at $20.01 and the price has moved by -28.65% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CryoLife Inc price has moved by -37.95% over the past year.

What are the analyst and broker recommendations for CryoLife Inc?

Of the analysts with advisory recommendations for CryoLife Inc, there are there are currently 2 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for CryoLife Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will CryoLife Inc next release its financial results?

CryoLife Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the CryoLife Inc dividend yield?

CryoLife Inc does not currently pay a dividend.

Does CryoLife Inc pay a dividend?

CryoLife Inc does not currently pay a dividend.

When does CryoLife Inc next pay dividends?

CryoLife Inc does not currently pay a dividend.

How do I buy CryoLife Inc shares?

To buy shares in CryoLife Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of CryoLife Inc?

Shares in CryoLife Inc are currently trading at $20.01, giving the company a market capitalisation of £583.2m.

Where are CryoLife Inc shares listed? Where are CryoLife Inc shares listed?

Here are the trading details for CryoLife Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: CRY
What kind of share is CryoLife Inc?

Based on an overall assessment of its quality, value and momentum, CryoLife Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a CryoLife Inc share price forecast 2020?

Shares in CryoLife Inc are currently priced at $20.01. At that level they are trading at 30.2% discount to the analyst consensus target price of 0.00.

Analysts covering CryoLife Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.11 for the next financial year.

How can I tell whether the CryoLife Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CryoLife Inc. Over the past six months, the relative strength of its shares against the market has been -32.15%. At the current price of $20.01, shares in CryoLife Inc are trading at -13.06% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the CryoLife Inc PE Ratio?

We were not able to find PE ratio data for CryoLife Inc.

Who are the key directors of CryoLife Inc?

CryoLife Inc's management team is headed by:

Ronald McCall - LED
D. Ashley Lee - CFO
Thomas Ackerman - IND
Daniel Bevevino - IND
Amy Horton - CAO
Scott Capps - VPR
James Mackin - CHM
Jean Holloway - SVP
John Davis - SVP
James Bullock - IND
Jeffrey Burbank - IND
Marna Borgstrom - IND
Michael Simpson - SVP
Thomas Bogenschutz - SVP
Matthew Getz - VPR
Dennis Maier - VOP
Who are the major shareholders of CryoLife Inc?

Here are the top five shareholders of CryoLife Inc based on the size of their shareholding:

BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 14.11% (5.33m shares)
Capital Research Global Investors Investment Advisor
Percentage owned: 7.81% (2.95m shares)
American Funds SMALLCAP World Fund Mutual Fund
Percentage owned: 7.07% (2.67m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 6.47% (2.44m shares)
iShares Core S&P Small-Cap ETF Mutual Fund
Percentage owned: 6.16% (2.33m shares)
Similar to CRY
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.